Skip to main content

Research Repository

Advanced Search

Functional desensitization of the ? 2 adrenoceptor is not dependent on agonist efficacy

Rosethorne, Elizabeth M.; Bradley, Michelle E.; Kent, Toby C.; Charlton, Steven J.

Functional desensitization of the ? 2 adrenoceptor is not dependent on agonist efficacy Thumbnail


Authors

Elizabeth M. Rosethorne

Michelle E. Bradley

Toby C. Kent

Profile Image

STEVEN CHARLTON Steven.Charlton@nottingham.ac.uk
Professor of Molecular Pharmacology and Drug Discovery



Abstract

© 2015 John Wiley & Sons Ltd, British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics. Chronic treatment with β2 adrenoceptor agonists is recommended as a first-line maintenance therapy for chronic obstructive pulmonary disease (COPD). However, a potential consequence of long-term treatment may be the loss of functional response (tachyphylaxis) over time. In this study, we have investigated the tendency of such agonists, with a range of efficacies, to develop functional desensitization to cAMP responses in primary human bronchial smooth muscle cells following prolonged agonist exposure. The data show that upon repeat exposure, all agonists produced functional desensitization to the same degree and rate. In addition, β2 adrenoceptor internalization and β-arrestin-2 recruitment were monitored using β2·eGFP visualization and the PathHunter™ β-arrestin-2 assay, respectively. All agonists were capable of causing robust receptor internalization and β-arrestin-2 recruitment, the rate of which was influenced by agonist efficacy, as measured in those assays. In summary, although a relationship exists between agonist efficacy and the rate of both receptor internalization and β-arrestin-2 recruitment, there is no correlation between agonist efficacy and the rate or extent of functional desensitization.

Citation

Rosethorne, E. M., Bradley, M. E., Kent, T. C., & Charlton, S. J. (2015). Functional desensitization of the ? 2 adrenoceptor is not dependent on agonist efficacy. Pharmacology Research and Perspectives, 3(1), https://doi.org/10.1002/prp2.101

Journal Article Type Article
Acceptance Date Sep 11, 2014
Online Publication Date Jan 5, 2015
Publication Date 2015-02
Deposit Date Mar 16, 2018
Publicly Available Date Jan 27, 2020
Print ISSN 2052-1707
Electronic ISSN 2052-1707
Publisher Wiley Open Access
Peer Reviewed Peer Reviewed
Volume 3
Issue 1
Article Number e00101
DOI https://doi.org/10.1002/prp2.101
Public URL https://nottingham-repository.worktribe.com/output/1118623
Publisher URL https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1002/prp2.101
PMID 25692019